In less than a decade, the resources available to treat light chain (AL) amyloidosis have increased impressively.
Giovanni Palladini, MD, PhD
Advertisement
Articles by Giovanni Palladini, MD, PhD
Advertisement
Latest Updated Articles
- Uniform Risk-Stratification and Response Criteria Are Paving the Way to Evidence-Based Treatment of AL Amyloidosis
Published: June 15th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?
2
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
3
Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment
4
Managing Early Adverse Events With Amivantamab + Lazertinib
5
